Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:7896657rdf:typepubmed:Citationlld:pubmed
pubmed-article:7896657lifeskim:mentionsumls-concept:C0085271lld:lifeskim
pubmed-article:7896657lifeskim:mentionsumls-concept:C0087111lld:lifeskim
pubmed-article:7896657lifeskim:mentionsumls-concept:C0027360lld:lifeskim
pubmed-article:7896657lifeskim:mentionsumls-concept:C1704632lld:lifeskim
pubmed-article:7896657lifeskim:mentionsumls-concept:C0871261lld:lifeskim
pubmed-article:7896657lifeskim:mentionsumls-concept:C2911692lld:lifeskim
pubmed-article:7896657lifeskim:mentionsumls-concept:C1706817lld:lifeskim
pubmed-article:7896657lifeskim:mentionsumls-concept:C0085973lld:lifeskim
pubmed-article:7896657pubmed:issue2lld:pubmed
pubmed-article:7896657pubmed:dateCreated1995-4-24lld:pubmed
pubmed-article:7896657pubmed:abstractTextOpioid receptor antagonists have been studied in the management of self-injurious behavior (SIB) in developmentally disabled individuals. The authors present a case of a severely retarded, autistic man whose SIB increased dramatically during a trial of naltrexone. A paradoxical increase in SIB, attributed to the extinction burst phenomenon during the initial period of nonreward, is known to occur during treatment with naloxone, a short-acting parenteral opioid antagonist. It has only once been reported during treatment with naltrexone, a long-acting orally administered agent. Opioid analgesic effects and learning theory can explain both increases and decreases in SIB after opioid blockade.lld:pubmed
pubmed-article:7896657pubmed:languageenglld:pubmed
pubmed-article:7896657pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7896657pubmed:citationSubsetIMlld:pubmed
pubmed-article:7896657pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7896657pubmed:statusMEDLINElld:pubmed
pubmed-article:7896657pubmed:monthFeblld:pubmed
pubmed-article:7896657pubmed:issn0890-8567lld:pubmed
pubmed-article:7896657pubmed:authorpubmed-author:GagnonMMlld:pubmed
pubmed-article:7896657pubmed:authorpubmed-author:PriceEElld:pubmed
pubmed-article:7896657pubmed:authorpubmed-author:BenjaminSSlld:pubmed
pubmed-article:7896657pubmed:authorpubmed-author:SeekAAlld:pubmed
pubmed-article:7896657pubmed:authorpubmed-author:TresiseLLlld:pubmed
pubmed-article:7896657pubmed:issnTypePrintlld:pubmed
pubmed-article:7896657pubmed:volume34lld:pubmed
pubmed-article:7896657pubmed:ownerNLMlld:pubmed
pubmed-article:7896657pubmed:authorsCompleteYlld:pubmed
pubmed-article:7896657pubmed:pagination238-42lld:pubmed
pubmed-article:7896657pubmed:dateRevised2011-11-17lld:pubmed
pubmed-article:7896657pubmed:meshHeadingpubmed-meshheading:7896657-...lld:pubmed
pubmed-article:7896657pubmed:meshHeadingpubmed-meshheading:7896657-...lld:pubmed
pubmed-article:7896657pubmed:meshHeadingpubmed-meshheading:7896657-...lld:pubmed
pubmed-article:7896657pubmed:meshHeadingpubmed-meshheading:7896657-...lld:pubmed
pubmed-article:7896657pubmed:meshHeadingpubmed-meshheading:7896657-...lld:pubmed
pubmed-article:7896657pubmed:meshHeadingpubmed-meshheading:7896657-...lld:pubmed
pubmed-article:7896657pubmed:meshHeadingpubmed-meshheading:7896657-...lld:pubmed
pubmed-article:7896657pubmed:meshHeadingpubmed-meshheading:7896657-...lld:pubmed
pubmed-article:7896657pubmed:meshHeadingpubmed-meshheading:7896657-...lld:pubmed
pubmed-article:7896657pubmed:year1995lld:pubmed
pubmed-article:7896657pubmed:articleTitleCase study: paradoxical response to naltrexone treatment of self-injurious behavior.lld:pubmed
pubmed-article:7896657pubmed:affiliationDepartment of Psychiatry, University of Massachusetts Medical Center, Worcester 01655.lld:pubmed
pubmed-article:7896657pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:7896657pubmed:publicationTypeCase Reportslld:pubmed